Phase 2 Carcinoma, Hepatocellular Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 1Phase 2
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma+4 more
Pfizer138 enrolled11 locationsNCT07227012
Recruiting
Phase 2
A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Asan Medical Center33 enrolled1 locationNCT07010497
Recruiting
Phase 2
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
Carcinoma, HepatocellularLiver Cell Carcinoma
Rutgers, The State University of New Jersey35 enrolled2 locationsNCT05366829
Recruiting
Phase 2
Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion
Carcinoma, Hepatocellular
University Hospital, Montpellier53 enrolled4 locationsNCT03727633
Recruiting
Phase 2
A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy
Carcinoma, Hepatocellular
Shanghai Henlius Biotech90 enrolled1 locationNCT06742892
Recruiting
Phase 2
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
Carcinoma, HepatocellularGastric Adenocarcinoma
National University Hospital, Singapore360 enrolled1 locationNCT06422403
Recruiting
Phase 2
A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.
Carcinoma, Hepatocellular
Shanghai Henlius Biotech117 enrolled1 locationNCT06349980
Recruiting
Phase 1Phase 2
A Study of PTX-9908 Injection for Non-resectable HCC with TACE
Carcinoma, Hepatocellular
TCM Biotech International Corp.50 enrolled1 locationNCT03812874
Recruiting
Phase 2
Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection
Carcinoma, Hepatocellular
Qilu Hospital of Shandong University30 enrolled1 locationNCT06454578
Recruiting
Phase 1Phase 2
ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Abivax S.A.48 enrolled2 locationsNCT03897543